NO303825B1 - Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene - Google Patents

Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene

Info

Publication number
NO303825B1
NO303825B1 NO932133A NO932133A NO303825B1 NO 303825 B1 NO303825 B1 NO 303825B1 NO 932133 A NO932133 A NO 932133A NO 932133 A NO932133 A NO 932133A NO 303825 B1 NO303825 B1 NO 303825B1
Authority
NO
Norway
Prior art keywords
derivatives
drugs
imidazolyl
intermediates
manufacture
Prior art date
Application number
NO932133A
Other languages
English (en)
Norwegian (no)
Other versions
NO932133L (no
NO932133D0 (no
Inventor
Ulrich E Mueller
J Rgen Dressel
Peter Fey
Rudolf H Hanko
Walter Huebsch
Thomas Kromer
Matthias Mueller-Gliemann
Martin Beuck
Stanislav Kazda
Andreas Knorr
Johannes-Peter Stasch
Stefan Wohlfeil
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO932133D0 publication Critical patent/NO932133D0/no
Publication of NO932133L publication Critical patent/NO932133L/no
Publication of NO303825B1 publication Critical patent/NO303825B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO932133A 1992-06-26 1993-06-10 Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene NO303825B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221009A DE4221009A1 (de) 1992-06-26 1992-06-26 Imidazolyl-substituierte Cyclohexanderivate

Publications (3)

Publication Number Publication Date
NO932133D0 NO932133D0 (no) 1993-06-10
NO932133L NO932133L (no) 1993-12-27
NO303825B1 true NO303825B1 (no) 1998-09-07

Family

ID=6461902

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932133A NO303825B1 (no) 1992-06-26 1993-06-10 Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene

Country Status (22)

Country Link
US (1) US5508299A (xx)
EP (1) EP0581003B1 (xx)
JP (1) JPH0673016A (xx)
KR (1) KR940000435A (xx)
CN (2) CN1037512C (xx)
AT (1) ATE196136T1 (xx)
AU (1) AU666732B2 (xx)
CA (1) CA2099078A1 (xx)
CZ (1) CZ282309B6 (xx)
DE (2) DE4221009A1 (xx)
ES (1) ES2151891T3 (xx)
FI (1) FI932952A (xx)
HU (1) HUT64753A (xx)
IL (1) IL106107A (xx)
MX (1) MX9303599A (xx)
NO (1) NO303825B1 (xx)
NZ (1) NZ247974A (xx)
PH (1) PH31425A (xx)
RU (1) RU2110514C1 (xx)
SK (1) SK281028B6 (xx)
TW (1) TW245713B (xx)
ZA (1) ZA934583B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW215434B (xx) * 1992-03-07 1993-11-01 Hoechst Ag
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
US5844318A (en) 1997-02-18 1998-12-01 Micron Technology, Inc. Aluminum film for semiconductive devices
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
AU2001267404A1 (en) * 2000-05-04 2001-11-12 Ipf Pharmaceuticals Gmbh Novel compounds for the treatment of inflammatory and cardiovascular diseases
US20240336638A1 (en) * 2021-07-01 2024-10-10 Guoqin ZHUGE Imidazole compound, and intermediate and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
SG50669A1 (en) * 1989-06-30 1998-07-20 Du Pont Fused-ring aryl subtituted imidazoles

Also Published As

Publication number Publication date
CN1182734A (zh) 1998-05-27
IL106107A (en) 1997-09-30
IL106107A0 (en) 1993-10-20
CZ282309B6 (cs) 1997-06-11
PH31425A (en) 1998-10-29
NO932133L (no) 1993-12-27
CA2099078A1 (en) 1993-12-27
FI932952A0 (fi) 1993-06-24
EP0581003A1 (de) 1994-02-02
CN1037512C (zh) 1998-02-25
AU666732B2 (en) 1996-02-22
RU2110514C1 (ru) 1998-05-10
AU4146393A (en) 1994-01-06
KR940000435A (ko) 1994-01-03
CZ117393A3 (en) 1994-01-19
NO932133D0 (no) 1993-06-10
SK66893A3 (en) 1994-02-02
DE59310098D1 (de) 2000-10-12
HU9301870D0 (en) 1993-09-28
SK281028B6 (sk) 2000-11-07
CN1082538A (zh) 1994-02-23
ZA934583B (en) 1994-02-02
FI932952A (fi) 1993-12-27
ATE196136T1 (de) 2000-09-15
MX9303599A (es) 1994-01-31
ES2151891T3 (es) 2001-01-16
HUT64753A (en) 1994-02-28
US5508299A (en) 1996-04-16
EP0581003B1 (de) 2000-09-06
JPH0673016A (ja) 1994-03-15
TW245713B (xx) 1995-04-21
DE4221009A1 (de) 1994-01-05
NZ247974A (en) 1996-07-26

Similar Documents

Publication Publication Date Title
FI925549A (fi) Nya azaheterocyklylmetyl-kromaner
ATE494009T1 (de) Prodrugs, ihre herstellung und verwendung als arzneimittel
DE3765270D1 (de) N-alpha-substituierte derivate von n-alpha-arylsulfonylaminoacyl-p-amidinophenylalaninamiden, deren herstellung, deren verwendung als arzneimittel und deren zwischenverbindungen.
CS782686A2 (en) Method of benzimidazole derivatives production
CS145091A3 (en) Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application
FI935728A (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
FI932105A0 (fi) Sulfonylbensylsubstituerade benso- och pyridopyridoner
NO303825B1 (no) Imidazolyl-substituerte cykloheksanderivater, legemidler inneholdende derivatene, anvendelse av derivatene for fremstilling av legemidler samt mellomprodukter for fremstilling av derivatene
FI925550A (fi) Piperidylmetyl-substituerade kromanderivat
NO301826B1 (no) Heterotricyklisk substituerte fenylcykloheksankarboksylsyrederivater, legemidler inneholdende dem og deres anvendelse for fremstilling av legemidler
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
ATE57179T1 (de) N-alpha-substituierte derivate von n-alphaarylsulfonylaminoacyl-pamidinophenylalaninamiden, deren herstellung, deren verwendung als arzneimittel und deren zwischenverbindungen.